A compelling story to communicate a technology's benefits to investors.

Client
Biotechnology scale-up
Services
Communication
A compelling story to communicate a technology’s benefits to investors

Background

A biotechnology company's proprietary microbial protein technology had rapidly moved from proof of concept to proof of scale in the last 2 years with the completion of its China production plant.
With the global climate and food security crises increasingly acute, the company wanted to restate the benefits of its microbial protein in a more compelling way, to engage stakeholders (including. potential investors) more effectively.

Approach

We worked closely with the company's Chief Technology Officer to develop and produce a short presentation to complement existing investor presentations: framing the audience, developing a story structure and producing an engaging investor-ready presentation.

Impact

Greater confidence in communicating the market need, technical process and product benefits to investors and stakeholders.

Complex scientific information conveyed with clarity to non-technical audiences through visual storytelling.

Increased likelihood of investment in a technology scale-up with huge potential for positive global impact.

Next steps

Keep exploring

Speak to our team

Our work in action

Sign-up for our latest insights.

Get in touch

We’d love to hear from you.

+44 (0)131 557 2667
info@graft.global
Get directions

GraftMarque-Light0

Privacy Policy
©2023 Graft Design & Innovation Management Ltd